TRIAD1 Is a Novel Transcriptional Target of p53 and Regulates Nutlin-3a-Induced Cell Death

Junwoo Lee1, Sungkwan An1, Yeong Min Choi1,2

  • 1Research Institute for Molecular-Targeted Drugs, Department of Biological Engineering, Konkuk University, Seoul, 05029, Republic of Korea.

Insights

Nutlin-3a

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Nutlin-3a is an MDM2 inhibitor investigated for cancer therapy.
  • Its efficacy is not solely dependent on MDM2 levels.
  • TRIAD1's role in Nutlin-3a's anticancer effects is unexplored.

Purpose of the Study:

  • To investigate the role of TRIAD1 in regulating the anticancer activity of Nutlin-3a.
  • To elucidate the mechanism of TRIAD1-mediated regulation of p53 activation by Nutlin-3a.

Main Methods:

  • In silico analysis and promoter luciferase assays to study TRIAD1 transcription.
  • TRIAD1 silencing and overexpression in cancer cells.
  • Cell viability, cell cycle, clonogenic, and soft-agar assays to assess Nutlin-3a's effects.

Main Results:

  • Nutlin-3a enhances TRIAD1 transcription in a p53-dependent manner via a p53 consensus sequence.
  • TRIAD1 silencing suppresses Nutlin-3a-induced p53 activation and target gene expression.
  • TRIAD1 knockdown reduces Nutlin-3a's cytotoxic and growth inhibitory effects in p53 wild-type cells.

Conclusions:

  • TRIAD1 acts as a positive regulator of Nutlin-3a-mediated p53 activation.
  • TRIAD1 is crucial for the cytotoxic activity of Nutlin-3a in cancer cells.
  • This highlights a novel feedback loop involving TRIAD1 and p53 in cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K